MIR6085

Across TCGA pan-cancer cohorts, MIR6085 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR6085 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR6085 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6085 expression acts as an unfavorable survival marker, although some lineages such as BLCA and TGCT show a favorable association.

KIRC, ESCA, and READ are the cancer types where MIR6085 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.520	0.674	<.001	129	view →
ESCA	OS	Tertile	All	0.416	0.724	.001	63	view →
READ	OS	Tertile	II,III,IV	0.054	0.934	<.001	54	view →
LIHC	OS	Tertile	All	0.466	0.792	.002	45	view →
STAD	DFS	Tertile	II,III,IV	0.340	0.569	.014	42	view →
GBM	DFS	Tertile	All	0.046	0.258	<.001	36	view →
ACC	OS	Tertile	All	0.133	0.686	.004	36	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	27	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	21	view →
THYM	OS	Tertile	III,IV	0.212	1.000	.014	18	view →
BLCA	OS	Tertile	II,III,IV	0.790	0.589	.027	18	view →
CESC	DFS	Tertile	II,III,IV	0.427	0.727	.003	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR6085–KIRC (OS)

Open the KIRC breakdown →